Two Seas Capital LP Esperion Therapeutics, Inc. Transaction History
Two Seas Capital LP
- $5.03 Billion
- Q3 2025
A detailed history of Two Seas Capital LP transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Two Seas Capital LP holds 9,749,724 shares of ESPR stock, worth $28.3 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
9,749,724
Previous 9,954,975
2.06%
Holding current value
$28.3 Million
Previous $9.76 Million
164.85%
% of portfolio
0.51%
Previous 0.18%
Shares
10 transactions
Others Institutions Holding ESPR
# of Institutions
213Shares Held
114MCall Options Held
643KPut Options Held
769K-
Black Rock Inc. New York, NY14MShares$40.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.1MShares$35.1 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT7.06MShares$20.5 Million0.1% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16.68MShares$19.4 Million7.68% of portfolio
-
Geode Capital Management, LLC Boston, MA4.75MShares$13.8 Million0.0% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $193M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...